This review presents data on ipilimumab and vemurafenib, 2 new targeted agents recently approved for the treatment of metastatic melanoma.
John A. Thompson, MD
Advertisement
Articles by John A. Thompson, MD
Advertisement
Latest Updated Articles
- New Prescribing Options in Metastatic Melanoma
Published: October 11th 2013 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Regular Melatonin Supplementation May Hide Hidden Heart Complications
2
From Type 1 to Type 2 and Beyond: Navigating the Landscape of Diabetes
3
COVID-19 During Pregnancy Raises Neurodevelopmental Risks in Children
4
Early Detection of Type 1 Diabetes: The Power of Screening and Preparation
5
